Health Technology Collaboration

US-based Thermo Fisher Scientific has entered a definitive agreement to divest its anatomical pathology business to Japanese healthcare firm PHC Holdings for a cash consideration of $1.14bn. Part of Thermo Fisher’s Specialty Diagnostics...

OR

platinum partners

gold partners

Silver Partners

Media Partners